Rifaximin
- Half-Life (t½)
- PO: 6h
- Formula
- C43H51N3O11
- Molecular Weight
- 785.88 g/mol
- Aliases
- Xifaxan
Pharmacological Mechanism
Non-absorbed rifamycin — minimal systemic exposure (<1% bioavailability) means minimal CYP induction despite same PXR mechanism. Used for travelers diarrhea, hepatic encephalopathy (gut ammonia), and IBS-D (gut microbiome modulation).
Half-Life & Elimination Curve (PO: 6h)
Elimination (PO)
- 0×t½0h100%
- 1×t½6h50%
- 2×t½12h25%
- 3×t½18h12.5%
- 4×t½24h6.3%
- 5×t½30h3.1%
Dosing Guidelines
- Oral (PO): Typical 400 mg (Range: 200–550 mg)
Pathways It Modulates
Target Organ Systems
Chemical Structure & Identifiers
- InChIKey: NZCRJKRKKOLAOJ-XRCRFVBUSA-N
- SMILES: C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C